Risk and Protective Factors for Childhood Asthma: What Is the Evidence?
- PMID: 27286779
- PMCID: PMC5107168
- DOI: 10.1016/j.jaip.2016.05.003
Risk and Protective Factors for Childhood Asthma: What Is the Evidence?
Abstract
To summarize the principal findings on risk and protective factors for childhood asthma, we retrieved systematic reviews on these topics in children (aged 1 to 18 years), up to January 2016, through MEDLINE, EMBASE, CINAHL, SCOPUS, and CDSR. A total of 227 studies were searched from databases. Among those, 41 systematic reviews (SRs) were included: 9 focused on prenatal factors, 5 on perinatal factors, and 27 on postnatal factors. Of these 41 SRs, 83% had good methodological quality, as determined by the Assess Systematic Reviews tool. After reviewing all evidence, parental asthma, prenatal environmental tobacco smoke, and prematurity (particularly very preterm birth) are well-established risk factors for childhood asthma. Current findings do suggest mild-to-moderate causal effects of certain modifiable behaviors or exposures during pregnancy (maternal weight gain or obesity, maternal use of antibiotics or paracetamol, and maternal stress), the perinatal period (birth by Caesarean delivery), or postnatal life (severe respiratory syncytial virus infection, overweight or obesity, indoor exposure to mold or fungi, and outdoor air pollution) on childhood asthma, but this suggestive evidence must be confirmed in interventional studies or (if interventions are not feasible) well-designed prospective studies.
Keywords: Asthma; Children; Meta-analysis; Protective factors; Risk factors; Wheeze.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.Pediatr Allergy Immunol. 2004 Jun;15 Suppl 16:4-5, 9-32. doi: 10.1111/j.1399-3038.2004.0148b.x. Pediatr Allergy Immunol. 2004. PMID: 15125698 Review.
-
Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants.J Toxicol Environ Health B Crit Rev. 2008 May;11(5-6):373-517. doi: 10.1080/10937400801921320. J Toxicol Environ Health B Crit Rev. 2008. PMID: 18470797 Review.
-
Preconceptional, prenatal and postnatal exposure to outdoor and indoor environmental factors on allergic diseases/symptoms in preschool children.Chemosphere. 2016 Jun;152:459-67. doi: 10.1016/j.chemosphere.2016.03.032. Epub 2016 Mar 19. Chemosphere. 2016. PMID: 27003368
-
Maternal smoking and environmental tobacco smoke exposure and the risk of allergic diseases in Japanese infants: the Osaka Maternal and Child Health Study.J Asthma. 2008 Nov;45(9):833-8. doi: 10.1080/02770900802339742. J Asthma. 2008. PMID: 18972305
-
Smoke exposure as a risk factor for asthma in childhood: a review of current evidence.Allergy Asthma Proc. 2014 Nov-Dec;35(6):454-61. doi: 10.2500/aap.2014.35.3789. Allergy Asthma Proc. 2014. PMID: 25584912 Review.
Cited by
-
A comparison of childhood asthma case definitions based on parent-reported data.Ann Epidemiol. 2021 Mar;55:64-68.e4. doi: 10.1016/j.annepidem.2020.10.001. Epub 2020 Oct 14. Ann Epidemiol. 2021. PMID: 33065267 Free PMC article.
-
Early-Life Antibiotic Exposure and Childhood Asthma Trajectories: A National Population-Based Birth Cohort.Antibiotics (Basel). 2023 Feb 3;12(2):314. doi: 10.3390/antibiotics12020314. Antibiotics (Basel). 2023. PMID: 36830225 Free PMC article.
-
Asthma and the Missing Heritability Problem: Necessity for Multiomics Approaches in Determining Accurate Risk Profiles.Front Immunol. 2022 May 25;13:822324. doi: 10.3389/fimmu.2022.822324. eCollection 2022. Front Immunol. 2022. PMID: 35693821 Free PMC article. Review.
-
Indoor metabolites and chemicals outperform microbiome in classifying childhood asthma and allergic rhinitis.Eco Environ Health. 2023 Aug 22;2(4):208-218. doi: 10.1016/j.eehl.2023.08.001. eCollection 2023 Dec. Eco Environ Health. 2023. PMID: 38435359 Free PMC article.
-
A review on the effect of COVID-19 in type 2 asthma and its management.Int Immunopharmacol. 2021 Feb;91:107309. doi: 10.1016/j.intimp.2020.107309. Epub 2020 Dec 30. Int Immunopharmacol. 2021. PMID: 33385710 Free PMC article. Review.
References
-
- Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376–380. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical